Excellent phase 2A results
of Q203 * (Telacebec)
presented at WHO
conference and published in AJRCCM

Open Lab facility for industry,
academia, and research
institute - Virus Research
Resource Center (RRC)

High-throughput screening of
small-molecules libraries identified
antibacterials against clinically
relevant multidrug-resistant
A. baumannii and K. pneumoniae